Related Experiment Video
Updated: Jun 14, 2026
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
The angiotensin AT2 receptor in inflammation
Franziska Rompe1, Thomas Unger, Ulrike Muscha Steckelings
1Center for Cardiovascular Research, Institute of Pharmacology, Charite-Universitatsmedizin Berlin, Berlin, Germany.
Drug News & Perspectives
|April 7, 2010
Summary
Chronic inflammation links to noninfectious diseases. The renin-angiotensin system (RAS) regulates inflammation, with the angiotensin AT(2) receptor showing anti-inflammatory potential, offering new therapeutic avenues.
Area of Science:
- Molecular Biology
- Immunology
- Endocrinology
Background:
- Chronic inflammation is a key factor in noninfectious diseases like autoimmune disorders, diabetes, and cardiovascular disease.
- The renin-angiotensin system (RAS), known for cardiovascular regulation, also plays a significant role in modulating inflammatory responses.
- Understanding the RAS's role in inflammation is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To review the role of the renin-angiotensin system (RAS) in inflammation.
- To specifically emphasize the function of the angiotensin AT(2) receptor in inflammatory processes.
- To explore the potential of AT(2) receptor stimulation as a novel anti-inflammatory therapeutic concept.
Main Methods:
- Review of existing scientific literature focusing on the RAS and inflammation.
- Analysis of data concerning the angiotensin AT(2) receptor's involvement in inflammatory pathways.
- Discussion of findings from animal models relevant to AT(2) receptor function in disease.
Main Results:
- The angiotensin AT(1) receptor is established as proinflammatory.
- Current evidence suggests a predominantly anti-inflammatory role for the angiotensin AT(2) receptor, though data are still limited and debated.
- Mechanisms of AT(2) receptor-mediated interference with proinflammatory pathways are being elucidated.
Conclusions:
- The AT(2) receptor presents a promising target for anti-inflammatory therapies.
- Further research is needed to clarify the AT(2) receptor's precise role and harness its therapeutic potential.
- Stimulation of the AT(2) receptor could represent a novel pharmacological strategy for managing inflammatory conditions.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...